| # | Drug | Count |
|---|---|---|
| 0 | AXICABTAGENE CILOLEUCEL | 58 |
| 1 | CILTACABTAGENE AUTOLEUCEL | 57 |
| 2 | CYCLOPHOSPHAMIDE | 51 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 51 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 51 |
| 5 | FLUDARABINE PHOSPHATE | 48 |
| 6 | ANAKINRA | 26 |
| 7 | TOCILIZUMAB | 26 |
| 8 | DEXAMETHASONE | 23 |
| 9 | DEXAMETHASONE 1.5 MG | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SILTUXIMAB | 19 | 0.0293 |
| 1 | OBECABTAGENE AUTOLEUCEL | 1 | 0.0141 |
| 2 | CILTACABTAGENE AUTOLEUCEL | 57 | 0.0087 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 18 | 0.0083 |
| 4 | IDECABTAGENE VICLEUCEL | 8 | 0.0064 |
| 5 | AXICABTAGENE CILOLEUCEL | 58 | 0.0057 |
| 6 | IMMUNE GLOBULIN INTRAVENOUS, HUMAN - DIRA | 1 | 0.0040 |
| 7 | LISOCABTAGENE MARALEUCEL | 2 | 0.0023 |
| 8 | DALBAVANCIN HYDROCHLORIDE | 1 | 0.0021 |
| 9 | TOCILIZUMAB-AAZG | 1 | 0.0016 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 19 | 0.0293 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 58 | 0.0057 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 26 | 0.0015 |
| 3 | CD22-directed Immunoconjugate [EPC] | 2 | 0.0007 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 2 | 0.0004 |
| 5 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Alkylating Drug [EPC] | 51 | 0.0002 |
| 9 | Thrombopoietin Receptor Agonist [EPC] | 3 | 0.0002 |